Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Effectiveness and cost-effectiveness of an educational intervention for practice teams to deliver problem focused therapy for insomnia: a pilot cluster randomised trial
ISRCTN ISRCTN55001433
ClinicalTrials.gov identifier
Public title Effectiveness and cost-effectiveness of an educational intervention for practice teams to deliver problem focused therapy for insomnia: a pilot cluster randomised trial
Scientific title
Acronym N/A
Serial number at source N/A
Study hypothesis Sleep problems are common, affecting two fifths of the population. Poor sleep (insomnia) is linked with psychological problems such as depression and physical problems such as high blood pressure, weight gain and heart disease. Many of those affected seek help from GPs whose response is often limited to sleep hygiene advice (a bedtime routine avoiding caffeine, alcohol, cigarettes or other stimulants) or prescription of sleeping pills (hypnotics) neither of which has been shown to be effective in the long term. Drugs for sleep difficulties are ineffective long term and probably do more harm than good, particularly in the elderly. Psychological/behavioural methods for managing sleep problems, termed cognitive behavioural therapy for insomnia (CBTi) have been shown to be effective and cost-effective when delivered by specialists but have not been fully evaluated in a general practice setting where they are most likely to be needed and most appropriately delivered.

Hypothesis:
Education for primary care teams in problem focused therapy for patients presenting to primary care with insomnia leads to better sleep outcomes for patients compared to treatment as usual with sleep hygiene up to three months from the beginning of treatment.
Lay summary
Ethics approval The North Nottingham Local Research Ethics Committee, approval received on the 16th September 2008 (ref: 08/H0406/128).
Study design Cluster randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Insomnia
Participants - inclusion criteria 1. At least 18 years old, either sex
2. Difficulty initiating and/or maintaining sleep for one month or more verified by Pittsburgh Sleep Quality Index (PSQI) score of greater than or equal to 5
3. New presentations with insomnia and existing patients on long term hypnotics
4. Points 1 - 3 above and sleep disrupted by painful conditions
5. Points 1 - 3 above and moderate/mild depression measured by the Beck Depression Inventory (BDI) (score 11 - 30)
Participants - exclusion criteria 1. Current or previous illicit substance or alcohol abuse
2. Pregnant or planning pregnancy in the next 12 months
3. Psychotic illness and severe depression defined by a BDI score greater than or equal to 31
4. Documented or active symptoms of sleep disruptive comorbid conditions, e.g. restless legs syndrome and any type of parasomnia
5. Obstructive sleep apnoea
6. Terminal illness
7. Inability to consent
Anticipated start date 01/09/2008
Anticipated end date 30/08/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details provided in the Interventions field to request a patient information sheet.
Target number of participants 80 patients recruited from 4 general practices (20 patients per practice)
Interventions We will undertake a pilot cluster randomised controlled trial (RCT) in which general practices are the unit of randomisation and where data will be collected from patients. Recruited general medical practices will be randomised to one of two arms; intervention consisting of education of primary care teams to use problem focused therapy for insomnia comprising sleep assessment tools (sleep diaries and Insomnia Severity Index) and modified cognitive behavioural therapy for insomnia (mCBTi); or a control arm using treatment as usual (TAU).

Patients will be involved in the study for a total of 13 weeks. Study outcomes will be measured at baseline, 4 weeks, 8 weeks and 13 weeks. Follow-up assessments will be performed using a telephone call at 2 weeks after the first treatment and self-completed postal questionnaires at all other timepoints. Non-responders will be telephoned 1 week after mailing the follow-up questionnaire on up to two occasions and posted a replacement questionnaire with a reminder letter if there is still no response at 2 weeks.

Please use the following contact details to request a patient information sheet:
Miss Tanefa Apekey
Research Assistant
REST Project
Lincolnshire Teaching PCT
Cross O'Cliff Court
Bracebridge Heath
Lincoln LN4 2HN
Tel: +44 (0)1522 515406
Primary outcome measure(s) Global sleep quality as measured by PSQI at 0, 4, 8 and 13 weeks.
Secondary outcome measure(s) Measured at 0, 4, 8 and 13 weeks:
1. The effect of the intervention on sleep outcome measures assessed with PSQI and sleep diaries:
1.1. Self reported sleep onset latency (SOL): how long it takes to fall asleep
1.2. Wake time after sleep onset (WASO): total hours awake at night after one has fallen asleep
1.3. Total time in bed (TIB)
1.4. Sleep efficiency (SE). Sleep efficiency, expressed as a percentage, is calculated as follows: SE = (100- [(SOL + WASO/TIB) x 100])
2. Daytime sleepiness (Epworth Sleepiness Scale)
3. Anxiety and depression using the generic Beck Depression Inventory
4. Health-related quality of life using EuroQol EQ-5D
5. Frequency of use and mean dose of hypnotic medication

Patients will also keep a Data Record Book (DRB) to record any adverse effects that participants might experience during the treatment period.
Sources of funding The Health Foundation (UK)
Trial website http://www.restproject.org.uk
Publications 2009 protocol in http://www.ncbi.nlm.nih.gov/pubmed/19171070
Contact name Prof  Niroshan  Siriwardena
  Address Professor of Primary Care, University of Lincoln
Faculty of Health, Life & Social Sciences
University of Lincoln
Brayford Pool
  City/town Lincoln
  Zip/Postcode LN6 7TS
  Country United Kingdom
  Tel +44 (0)1522 886939
  Fax +44 (0)1522 837058
  Email nsiriwardena@lincoln.ac.uk
Sponsor Lincolnshire Primary Care Trust (UK)
  Address c/o Mrs Lynne Moody
Head of Professional Standards
Teaching PCT and Research (Deputy Director)
Cross O'Cliff Court
Bracebridge Heath
  City/town Lincoln
  Zip/Postcode LN4 2HN
  Country United Kingdom
  Tel +44 (0)1522 513355
  Fax +44 (0)1522 540706
  Email lynne.moody@lpct.nhs.uk
  Sponsor website: http://www.lpct.nhs.uk
Date applied 27/06/2008
Last edited 13/02/2009
Date ISRCTN assigned 31/07/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central